For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
|
|
| Basic information |
| Chairman |
President |
Spokesperson |
Telephone |
Address |
ESM Registration Date |
| Vincent Lin |
Grace Fu |
Vincent Lin |
02-26581218 |
10F., No. 185-1, Gangqian Rd., Neihu Dist.,Taipei City , Taiwan (R.O.C.) |
2022/01/25 |
| Industrycategory |
Key businesses |
| Biotechnology and Medical Care |
The company mainly provides services such as genetic testing services, cell product manufacturing, virus testing reagents, cell experiment services, and personalized genetic health food.
Cell therapy development:
TCI gene R&D department has developed ADSC、NK、DC-CIK cell processes and has completed the application for GTP certification for adipose-derived mesenchymal stem cells and natural killer cells.
LDTs laboratory independent detection technology development:
The development of drug-gene detection technology for cardiovascular, diabetes, depression, insomnia, etc., combined with the hospital drug database”, based on the results of genetic testing and drug response, to achieve accurate medical drugs.
R PCR detection influenza kit:
The isothermal amplification PCR technology overcomes the limitations of the current traditional PCR technology, such as the need for professional laboratories, professionals, the detection time is too long, and the need for professional judgment. |
| Financial data |
| Cash flows statement
| Item
|
|
|
| Amount(NTD, in thousands) |
| Cash flows from operating activities |
|
|
| Cash flows from investing activities |
|
|
| Cash flows from financing activities |
|
|
Consolidated/Individual
balance sheet
|
Current assets |
|
|
| Non-current assets |
|
|
| Total assets |
|
|
| Current liabilities |
|
|
| Non-current liabilities |
|
|
| Total liabilities |
|
|
| Share capital |
|
|
| Capital surplus |
|
|
| Retained earnings |
|
|
| Other equity interest |
|
|
| Treasury shares |
|
|
| Total equity attributable to owners of parent |
|
|
| Non-controlling interests |
|
|
| Total equity |
|
|
| Book Value per share(NT$) |
|
|
Consolidated/Individual
profit and loss
statement |
Operating revenue |
|
|
| Operating costs |
|
|
| Gross profit from operations |
|
|
| Operating expenses |
|
|
| Net other income (expenses) |
|
|
| Net operating income |
|
|
| Non-operating income and expenses |
|
|
| Profit before tax |
|
|
| Tax expense |
|
|
| Profit from continuing operations |
|
|
| Profit from discontinued operations |
|
|
| Profit |
|
|
| Other comprehensive income |
|
|
| Comprehensive income |
|
|
| Basic earnings per share |
|
|
 Auditor's report on latest financial statements： auditor's report：
|
|
Investors may find more detailed information on the company by visiting the Market Observation Post System.。
|
|
The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.
|
